BTG Pactual Global Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

BTG Pactual Global Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,500	Closed	-$256K	–	190
2020 Q2	$256K	Sell	3,500 -4,000	-53%	-$213K	0.04%	101
2020 Q1	$255K	Buy	+7,500	New	+$343K	0.04%	98
2019 Q4	–	Sell	-15,906	Closed	-$664K	–	119
2019 Q3	$664K	Buy	15,906 +5,906	+59%	+$250K	0.3%	45
2019 Q2	$438K	Buy	+10,000	New	+$564K	0.11%	56

Other funds holding BHVN

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BTG Pactual Global Asset Management's BHVN Position: Q3 2020 in Review

BTG Pactual Global Asset Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2020, closing a stake of 3,500 shares — an estimated $256K sold.

BTG Pactual Global Asset Management first reported a position in BHVN in Q2 2019 and held it in 4 quarters. The position peaked at $664K in Q3 2019. 215 funds tracked by Wall St. Rank hold BHVN as of Q3 2020.

BTG Pactual Global Asset Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2020 after selling out during the quarter.
BTG Pactual Global Asset Management sold 3,500 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2020, an estimated $256K.
BTG Pactual Global Asset Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2019 and held it in 4 quarters.
BTG Pactual Global Asset Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $664K in Q3 2019.
215 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2020.

Based on BTG Pactual Global Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.